An Overview of Amyotrophic Lateral Sclerosis

JAMA Clinical Reviews by American Medical Association

May 11, 202617:34Health

Amyotrophic lateral sclerosis (ALS), which affects about 25 000 individuals in the US, causes progressive weakness but has varied presentations. Several FDA-approved medications are now available for ALS. Author John Rav...

Related Episodes

Continue listening to more episodes from JAMA Clinical Reviews.

An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

Aug 24, 2026 - 28:43

POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem s...

Medication Treatments for Alcohol Use Disorder

Aug 19, 2026 - 20:14

Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment...

Liquid Biopsy Tests for Cancer

Aug 10, 2026 - 23:48

Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cance...

Patient-Clinician Communication About Physical Activity

Aug 6, 2026 - 10:35

Physical activity is an effective component of care for people with chronic medical conditions. In this p...

Classic Hodgkin Lymphoma

Aug 3, 2026 - 20:59

Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally...

The Sleep-Weight Connection

Jul 29, 2026 - 13:59

Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losi...

Management of Dyslipidemia

Jul 20, 2026 - 23:22

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongl...

Hip Fractures: Management and Prevention

Jul 16, 2026 - 19:23

Hip fractures are a leading cause of disability and death in older adults. This episode summarizes risk f...